Fleischmann, Maximilian
Schnetzke, Ulf
Frietsch, Jochen J.
Sayer, Herbert G.
Schrenk, Karin
Hammersen, Jakob
Glaser, Anita
Hilgendorf, Inken
Hochhaus, Andreas
Scholl, Sebastian http://orcid.org/0000-0003-2893-3630
Funding for this research was provided by:
Universitätsklinikum Jena
Article History
Received: 26 May 2021
Accepted: 7 July 2021
First Online: 23 July 2021
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. The authors have no conflicts of interest to declare that are relevant to the content of this article. The authors have no financial or proprietary interests in any material discussed in this article.
: All patients were included in one of the following AML registries: AML registry of the OSHO study group (East German Study Group of Hematology and Oncology) or in the SAL registry (Study Alliance Leukemia). Patients gave their written informed consent for data acquisition and analysis after pseudonymization in one of the AML registries. The participation in both AML registries has been approved by the Ethical review committee of the University Hospital Jena.
: The presented study does not include research involving animals or pharacological research in human participants. The presented retrospective study was performed according to the Declaration of Helsinki.